Will Thomas: Why Dose Every Missed Thromboprophylaxis Matter
Will Thomas, Consultant haematologist at Cambridge University Hospitals NHS Foundation Trust, shared on LinkedIn about a recent article by Scott G. Louis et al, published in JAMA Surgery, adding:
“Experts are often asked to give an opinion on causation when there had been missed prophylactic low-molecular weight heparin doses and hospital acquired thrombosis.
One of the few things we can do is to avoid missed doses. This was identified by a previous GIRFT survey in 2021.
Every case is unique and requires meticulous attention to the circumstances and particular details of the case.
This paper gives valuable data in this area.
Which is helpful for experts albeit data remains limited.”
Title: Correlation of Missed Doses of Enoxaparin With Increased Incidence of Deep Vein Thrombosis in Trauma and General Surgery Patients
Authors: Scott G. Louis, Misa Sato, Travis Geraci, Ross Anderson, S. David Cho, Philbert Y. Van, Jeffrey S. Barton, Gordon M. Riha, Samantha Underwood, Jerome Differding, Jennifer M. Watters, Martin A. Schreiber
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 22, 2026, 16:20Ila Bappa Ibrahim: Bringing Sickle Cell Innovation Closer to Communities
-
Sep 22, 2026, 16:02Ana Pedrero Gil: Peri-operative Management of Patients Undergoing Day Surgery
-
Sep 22, 2026, 15:27Zia Ullah: RBC-Derived Extracellular Vesicles as Potential Biomarkers of Thrombotic Risk in Dengue
-
Sep 22, 2026, 15:01Lesley Van Wyk: What Each Iron Markers Actually Mean
-
Sep 22, 2026, 14:37Chokri Ben LamineÖ‰ Saudi Arabia Leads A New Milestone In Hemophilia A Care
-
Sep 22, 2026, 13:58Giulia Passaniti: Dual Inferior Vena Cava Anatomy in Tetralogy of Fallot
-
Sep 22, 2026, 13:35Michael Miyamoto: Scaling Guideline Based Lipid Management in Community Practice
-
Sep 22, 2026, 13:15Suvro Sankha Datta: Developing Blood Group Genotyping Platform Using a Gold-Oligo
-
Sep 22, 2026, 13:07Caitlin Raymond: The Plasma Chaser in Therapeutic Plasma Exchange